Table 1.
Incidence of IPD caused by NVTs in some studies mentioned above
| Pre-PCV13 period |
Post-PCV13 period |
|||||
|---|---|---|---|---|---|---|
| Country | Age | Year | NVT-associated IPD (/100,000) | Year | NVT-associated IPD (/100,000) | Most prevalent serotypes |
| England11 | All | 2012–2013 | 4.19 | 2013–2014 | 5.25 | - |
| <2 years | 2012–2013 | 10.83 | 2013–2014 | 12.03 | - | |
| 2–4 years | 2012–2013 | 3.63 | 2013–2014 | 4.08 | - | |
| England17 | <5 years; >45 years | 2013–2014 | - | 2016–2017 | - | 8, 12 F, and 9 N |
| German15 | <16 years | 2012–2013 | 1.1 | 2015–2016 | 2.5 | - |
| Gambia16 | 2–59 months | Before 2011 | 14 | After 2011 | 78 | - |
| 2–23 months | 2010 | 49 | 2011 | 75 | - | |
| Israel18 | All | 2009 | 0.32a | 2015 | 0.75b | 15B/C, 6 C, 23A, 23B, 24 F |
aOnly the incidence of meningitis (not IPD) is included.